CNS Pharmaceuticals, Inc. - Price History
Monthly price history for CNSP (CNS Pharmaceuticals, Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| May 2024 | $0.22 | $0.22 |
| April 2024 | $0.21 | $0.21 |
| March 2024 | $0.36 | $0.36 |
| February 2024 | $0.28 | $0.28 |
| January 2024 | $0.25 | $0.25 |
| December 2023 | $1.27 | $1.27 |
| November 2023 | $2.08 | $2.08 |
| October 2023 | $2.07 | $2.07 |
| September 2023 | $1.14 | $1.14 |
| August 2023 | $1.71 | $1.71 |
| July 2023 | $2.26 | $2.26 |
| June 2023 | $2.23 | $2.23 |
| May 2023 | $1.84 | $1.84 |
| April 2023 | $1.51 | $1.51 |
| March 2023 | $1 | $1 |
| February 2023 | $1.85 | $1.85 |
| January 2023 | $2.21 | $2.21 |
| December 2022 | $2.40 | $2.40 |
| November 2022 | $3.03 | $3.03 |
| October 2022 | $4.80 | $0.16 |
| September 2022 | $5.37 | $0.18 |
| August 2022 | $7.32 | $0.24 |
| July 2022 | $6.60 | $0.22 |
| June 2022 | $8.40 | $0.28 |
| May 2022 | $9.09 | $0.30 |
| April 2022 | $10.14 | $0.34 |
| March 2022 | $10.23 | $0.34 |
| February 2022 | $11.70 | $0.39 |
| January 2022 | $18.03 | $0.60 |
| December 2021 | $21.06 | $0.70 |
| November 2021 | $33.60 | $1.12 |
| October 2021 | $41.40 | $1.38 |
| September 2021 | $44.70 | $1.49 |
| August 2021 | $51 | $1.70 |
| July 2021 | $51.60 | $1.72 |
| June 2021 | $58.80 | $1.96 |
| May 2021 | $55.50 | $1.85 |
| April 2021 | $60 | $2 |
| March 2021 | $71.70 | $2.39 |
| February 2021 | $78.90 | $2.63 |
| January 2021 | $51.60 | $1.72 |
| December 2020 | $53.40 | $1.78 |
| November 2020 | $67.20 | $2.24 |
| October 2020 | $50.46 | $1.68 |
| September 2020 | $52.80 | $1.76 |
| August 2020 | $64.50 | $2.15 |
| July 2020 | $55.80 | $1.86 |
| June 2020 | $64.20 | $2.14 |
| May 2020 | $79.80 | $2.66 |
| April 2020 | $86.10 | $2.87 |
| March 2020 | $63 | $2.10 |
| February 2020 | $111.60 | $3.72 |
| January 2020 | $129.30 | $4.31 |
| December 2019 | $118.50 | $3.95 |
| November 2019 | $123.90 | $4.13 |
CNSP
Price: $0.22
52 week price:
Earnings Per Share: -10.00 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 89600
Market Capitalization: 2.6 million